000 01881 a2200529 4500
005 20250514211918.0
264 0 _c20050104
008 200501s 0 0 eng d
022 _a0016-5085
024 7 _a10.1053/j.gastro.2004.09.050
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZeuzem, Stefan
245 0 0 _aPeginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels.
_h[electronic resource]
260 _bGastroenterology
_cDec 2004
300 _a1724-32 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAlanine Transaminase
_xblood
650 0 4 _aAntiviral Agents
_xadministration & dosage
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aHepatitis C, Chronic
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aInjections, Subcutaneous
650 0 4 _aInterferon alpha-2
650 0 4 _aInterferon-alpha
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPolyethylene Glycols
_xadministration & dosage
650 0 4 _aRNA, Viral
_xanalysis
650 0 4 _aRecombinant Proteins
650 0 4 _aRibavirin
_xadministration & dosage
650 0 4 _aTreatment Outcome
700 1 _aDiago, Moisés
700 1 _aGane, Edward
700 1 _aReddy, K Rajender
700 1 _aPockros, Paul
700 1 _aPrati, Daniele
700 1 _aShiffman, Mitchell
700 1 _aFarci, Patrizia
700 1 _aGitlin, Norman
700 1 _aO'Brien, Christopher B
700 1 _aLamour, François
700 1 _aLardelli, Pilar
773 0 _tGastroenterology
_gvol. 127
_gno. 6
_gp. 1724-32
856 4 0 _uhttps://doi.org/10.1053/j.gastro.2004.09.050
_zAvailable from publisher's website
999 _c15263450
_d15263450